Hollencrest Capital Management’s CapForce IBD Breakout Opportunities ETF BOUT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.7K Hold
450
﹤0.01% 747
2025
Q4
$16.3K Hold
450
﹤0.01% 743
2025
Q3
$17.5K Hold
450
﹤0.01% 725
2025
Q2
$16.5K Hold
450
﹤0.01% 701
2025
Q1
$16.3K Hold
450
﹤0.01% 708
2024
Q4
$17.6K Hold
450
﹤0.01% 712
2024
Q3
$16.5K Buy
450
+160
+55% +$5.71K ﹤0.01% 697
2024
Q2
$10.1K Hold
290
﹤0.01% 745
2024
Q1
$10.5K Hold
290
﹤0.01% 710
2023
Q4
$9.59K Hold
290
﹤0.01% 728
2023
Q3
$8.8K Hold
290
﹤0.01% 744
2023
Q2
$9.36K Hold
290
﹤0.01% 763
2023
Q1
$9.04K Hold
290
﹤0.01% 760
2022
Q4
$8.58K Buy
+290
New +$8.72K ﹤0.01% 744

Other funds holding BOUT

Hollencrest Capital Management's BOUT Position: Q1 2026 in Review

Hollencrest Capital Management held its CapForce IBD Breakout Opportunities ETF (BOUT) position steady in Q1 2026 at 450 shares worth $17.7K. The position accounts for ﹤0.01% of the portfolio, ranked #747.

Hollencrest Capital Management first reported a position in BOUT in Q4 2022 and has held it in 14 quarters since. 14 funds tracked by Wall St. Rank hold BOUT as of Q1 2026.

  • Hollencrest Capital Management held 450 shares of CapForce IBD Breakout Opportunities ETF worth $17.7K as of Q1 2026.
  • Hollencrest Capital Management left its CapForce IBD Breakout Opportunities ETF share count unchanged in Q1 2026.
  • CapForce IBD Breakout Opportunities ETF made up ﹤0.01% of Hollencrest Capital Management's portfolio in Q1 2026, its #747 holding.
  • Hollencrest Capital Management first reported a position in CapForce IBD Breakout Opportunities ETF in Q4 2022 and has held it in 14 quarters since.
  • 14 funds tracked by Wall St. Rank held CapForce IBD Breakout Opportunities ETF as of Q1 2026.

Based on Hollencrest Capital Management's 13F filing for Q1 2026, filed 7 May 2026.